Evaluation of dual-trigger regimen in improving outcomes for pregnancy in different ovarian respond patients: a retrospective study

Author:

Wang Jinrong1,Xu Ke2,Yang Shuangshuang3,Hou Ning3,Sun Mei4

Affiliation:

1. Chinese Academy of Medical Sciences & Peking Union Medical College

2. Shandong University

3. Shandong Provincial Hospital Affiliated to Shandong First Medical University

4. Center for Reproductive Medicine, Shandong University

Abstract

Abstract Objective Observing pregnancy outcomes of patients who used dual-trigger and single-trigger regimens in different ovarian responders who received ART, and assessing the effectiveness and safety of the regimens to provide insights into the optimization of clinical strategy. Methods The clinical profile of 2778 infertile patients who received ART (IVF/ICSI) were reviewed and collected retrospectively. Patients enrolled with different ovarian responses were divided into single-trigger and dual-trigger groups based on different real-world trigger protocols. The baseline characteristics, ovulation induction and pregnancy outcomes of the patients were statistically analyzed. Results There were no significant differences in characteristics of the baseline and cycle parameters on the two trigger regimen groups for high responders, normal responders and low responders. The number of oocytes and the oocytes retrieval rate by the dual trigger of normal responders and high responders have increased, but there were no significant differences in pregnancy outcomes (embryo transfer rate, pregnancy rate, live birth rate) between trigger groups. The dual trigger had a lower transplant cancellation rate due to prevention of OHSS: high responders (P = 0.927), normal responders (P = 0.251). In poor responders, there were no cases of transplantation cancellation for OHSS prevention in both groups. Conclusion The dual trigger is a relatively effective and safe regimen for patients with high response and normal ovarian response. In patients with poor ovarian response, the evidence for reducing the risk of OHSS is not sufficient. Further validation in larger, well-designed randomized controlled trials on whether dual triggering improves pregnancy outcomes in poor responders is needed.

Publisher

Research Square Platform LLC

Reference22 articles.

1. 1. Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med. 2012;9(12):e 1001356. doi: 10.1371/journal.pmed.1001356.

2. 2. Albeitawi S, Marar EA, Reshoud FA, Hamadneh J, Hamza R, Alhasan G, Omeish H, Vigano P. Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves oocyte yield in normal responders on GnRH-antagonist cycles. JBRA Assist Reprod. 2022 Jan 17;26(1): 28–32. doi:10.5935/1518-0557.20210039. Gonen Y, Balakier H, Powell W, Casper RF. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab. 1990 Oct;71(4):918 − 22. doi: 10.1210/jcem-71-4-918.

3. 4. Itskovitz-Eldor J, Kol S, Mannaerts B. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication. Hum Reprod, 2000;15(9): 1965–1968. doi: 10.1093/humrep/15.9.1965.

4. 5. JIAO Min-jie, ZHANG Yun-shan, ZHANG Yin-feng. Progression in the use of gonadotropin-releasing hormone antagonists in controlled ovarian hyperstimulation. Shandong Medical Journal. 2016;56(20): 100–102.

5. 6. Marci R, Graziano A, Lo Monte G, Piva I, Soave I, Marra E, Lisi F, Moscarini M, Caserta D. GnRH antagonists in assisted reproductive techniques: a review on the Italian experience. Eur Rev Med Pharmacol Sci. 2013 Apr;17(7):853 − 73.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3